Credit bearing module SACT Administration and Patient Care
Explore sact administration and patient care and develop knowledge to inform your understanding and professional practice.
Key facts
- Duration
- Part time: Two semesters: SACT passport submission - end of the first semester Academic assignment submission - mid second semester
- Level
- Continuing professional development (CPD)
- Academic level
- 6
- Academic credits
- 15
- School
- Oxford School of Nursing and Midwifery
- Application deadline
- 22 August 2026 (for September start)
- 21 December 2026 (for January 2027 start)
About this course
This is a practice module designed for registered nurses who are required to administer systemic anti-cancer therapy (SACT), or in the case of uro-oncology nurses, intravesical anti-cancer treatment. It will provide you with the opportunity to develop an in-depth understanding of systemic anti-cancer treatments (SACTs). You will develop the required knowledge and skills to be able to autonomously, safely and competently administer systemic or intravesical anti-cancer therapy.
This module has been designed by professionals experienced in delivering a range of cancer care education, as well as being involved in current practice in the administration of systemic or intravesical anti-cancer therapy. The content of this course aligns with National Chemotherapy Measures (NICE 2018) and the UKONS SACT Competency Passport (2019).
Entry requirements
Entry requirements
You must have:
- Nursing Midwifery Council Registration.
- Evidence of support of the manager from practice area.
- Signed Practice Assessor Form to evidence nominated practice assessor who can supervise and assess practice learning.
- Be employed or have access to a health care setting that will enable achievement of the learning outcomes.
- Competence in administration of non-cytotoxic intravenous medication including bolus infusions for students gaining competence in administration of intravenous anti-cancer treatments.
- Competence in cannulation for students gaining competence in administration of intravenous anti-cancer treatments to adult patients.
- Competence in urethral catheterisation (male and female) for students gaining competence in administration of intravesical anti-cancer treatments.
Please contact the Module Leader so that you can discuss the specific practice assessment requirements.
This course is not available to international students who require a student sponsor to study in the UK.
Fees and funding
Fees
| Fee types | 2026/27 |
|---|---|
| Home part-time | £1,260 per single module |
How and when to pay
Tuition fee instalments for the semester are due by the Monday of week 1 of each semester. Students are not liable for full fees for that semester if they leave before week 4. If the leaving date is after week 4, full fees for the semester are payable.
- For information on payment methods please see our Make a Payment page.
- For information about refunds please visit our Refund policy page.
Questions about fees?
Learning and assessment
The teaching, learning and assessment strategy of the module reflects its student centred, patient-centred and practice-focused approach. The module has an appropriate division between structured learning activities and private study. All of the learning methods to be used will engage the student in both academic and practice learning.
You will have to undertake a period of supervised practice in the administration of systemic or intravesical anti-cancer therapy to gain competence in administering systemic or intravesical anti-cancer therapy against learning outcomes. This will be in your own place of work or a practice setting in which systemic or intravesical anti-cancer therapy is given. This will be arranged by your manager, under the supervision of an agreed practice assessor nominated by your manager who meets current national standards, such as the Cancer Measures Chemotherapy Assessor standards.
The module explores the biological mechanisms targeted by SACTs, the mechanism of action of SACT, treatment efficacy and side effects of individual drugs. It focuses on the use of stratified healthcare, based on pharmacogenomics data, and the management of treatment-related toxicities in patients receiving SACTS, illustrated by patient case studies.
The teaching sessions will incorporate the following, delivered over 4 learning units:
- Cancer biology and rationale for using SACT and intravesical anti-cancer therapy
- Pharmacology of systemic and intravesical anti-cancer therapy
- Uses of systemic and anti-cancer therapy
- Current developments: clinical trials, targeted therapies, personalised medicine
- Electronic SACT prescriptions and prescription issues
- Pre-SACT patient assessment
- The patient experience of SACT
Assessment
The assessment is in 2 parts – you must pass both components to pass the module:
- UKONS Passport/Workbook
- Critical reflection OR poster presentation
Careers
The taught part of this module takes place online during semester one, designed to support student completion of the UKONS SACT Passport/Workbook. After submission for marking of both the theory and practical sections of the SACT Passport/Workbook at the end of semester one, students will work on the written or poster assignment during semester two. They will focus on an issue relevant to SACT administration and their role as a SACT nurse.
How to apply
Apply through our Moodle Portal.
You will need to register for the portal prior to proceeding with an application.
Our courses are reviewed regularly as part of our quality assurance framework, so module availability and course structures may vary from what is listed here. On rare occasions, we may also need to make updates to our course programmes after publication; for full details, please visit our changes to programmes page (opens in a new tab)